These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 839583)

  • 1. Role of hormones in growth kinetics of renal cell carcinoma in vitro.
    Cummings KB; Wheelis RF; Nelson FW
    J Urol; 1977 Mar; 117(3):269-71. PubMed ID: 839583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
    Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of rat prostatic adenocarcinoma with medroxyprogesterone acetate (MPA): effects on growth and morphology.
    Damber JE; Bergh A; Landström M; Tomić R
    J Urol; 1991 Jun; 145(6):1283-7. PubMed ID: 1827847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.
    Klaassen DJ; Rapp EF; Hirte WE
    Cancer Treat Rep; 1976 Mar; 60(3):251-3. PubMed ID: 1260780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of metastasizing hypernephroid (renal cell) carcinoma with medroxyprogesterone acetate (Clinovir) (author's transl].
    von Lieven H; Hahn D
    MMW Munch Med Wochenschr; 1977 Aug; 119(34):1089-92. PubMed ID: 408657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H-thymidine incorporation under endocrine influence and hormone receptor content of human mammary carcinoma (author's transl)].
    von Matthiessen H; Koldovsky U; Feldhammer B
    Dtsch Med Wochenschr; 1980 Oct; 105(41):1424-7. PubMed ID: 7449644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of tumor growth and metastases by medroxyprogesterone acetate in transplanted uterine adenocarcinoma cells of the rat.
    Sekiya S; Yano A; Takamizawa H
    J Natl Cancer Inst; 1974 Jan; 52(1):297-8. PubMed ID: 4810970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
    Ouatas T; Halverson D; Steeg PS
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of hormones in treatment of metastatic testicular teratomas: tumour regression with medroxyprogesterone acetate.
    Bloom HJ; Hendry WF
    Br Med J; 1973 Sep; 3(5880):563-7. PubMed ID: 4726928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine renal cell carcinoma: a suitable human model.
    Murphy GP
    Prog Clin Biol Res; 1982; 100():175-206. PubMed ID: 6216486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate.
    Katakkar SB; Franks CR
    Cancer Treat Rep; 1978 Sep; 62(9):1379-80. PubMed ID: 688282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of progestogen in the treatment of metastatic carcinoma of the kidney and uterine body.
    Paine CH; Wright FW; Ellis F
    Br J Cancer; 1970 Jun; 24(2):277-82. PubMed ID: 5451569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Culture characteristics of human endometrial glandular epithelium throughout the menstrual cycle: modulation of deoxyribonucleic acid synthesis by 17 beta-estradiol and medroxyprogesterone acetate.
    Marshburn PB; Head JR; MacDonald PC; Casey ML
    Am J Obstet Gynecol; 1992 Dec; 167(6):1888-98. PubMed ID: 1471713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of breast cancer with medroxyprogesterone acetate.
    Muggia FM; Cassieth PA; Ochoa M; Flatow FA; Gellhorn A; Hyman GA
    Ann Intern Med; 1968 Feb; 68(2):328-37. PubMed ID: 4306126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The possible mechanisms of action of progestins on endometrial adenocarcinoma.
    Anderson DG
    Am J Obstet Gynecol; 1972 May; 113(2):195-211. PubMed ID: 4112650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
    Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL
    Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tamoxifen, medroxyprogesterone acetate and estradiol on tumor growth and oncogene expression in MCF-7 breast cancer cell line transplanted into nude mice.
    Mizukami Y; Tajiri K; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Nakamura S; Matsubara F
    Anticancer Res; 1991; 11(3):1333-8. PubMed ID: 1832273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct effects of medroxyprogesterone acetate, danazol, and leuprolide acetate on endometrial stromal cell proliferation in vitro.
    Surrey ES; Halme J
    Fertil Steril; 1992 Aug; 58(2):273-8. PubMed ID: 1386030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medroxyprogesterone acetate (Provera) in the treatment of metastatic renal cancer.
    Bloom HJ
    Br J Cancer; 1971 Jun; 25(2):250-65. PubMed ID: 5115827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.